AdaptHealth Corp. (NASDAQ:AHCO) saw a downside of -1.99% to close Monday at $13.30 after subtracting -$0.27 on the day. The 5-day average trading volume is 1,379,700 shares of the company’s common stock. It has gained $13.94 in the past week and touched a new high 2 times within the past 5 days. An average of 1,070,810 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,226,982.
AHCO’s 1-month performance is 8.48% or $1.04 on its low of $12.13 reached on 07/10/23. The company’s shares have touched a 52-week low of $9.32 and high of $26.49, with the stock’s rally to the 52-week high happening on 02/23/23. YTD, AHCO has lost -30.80% or -$5.92 and has reached a new high 9 times. However, the current price is down -49.79% from the 52-week high price.
Insider Transactions
AHCO stock investors last saw insider trading activity on Feb 06.Everest Hill Group Inc. (9% owner) most recently sold 540,000 shares at $20.75 per share on Feb 06. This transaction cost the insider $11,205,007. 9.9% owner, Everest Hill Group Inc., sold 44,789 shares at a price of $21.00 on Feb 01. Then, on Jan 31, 9.9% owner Everest Hill Group Inc. sold 55,211 shares at a price of $21.00 per share. This transaction amounted to $1,159,431.
Valuation Metrics
AHCO stock has a beta of 0.69. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.59 while the price-to-book (PB) in the most recent quarter is 0.83, with the price to cash flow ratio at 39.87.
AdaptHealth Corp.’s quick ratio for the period ended March 30 was 1.00, with the current ratio over the same period at 1.20. As well, the company’s long term debt to equity for the quarter ending March 30 was 1.01, while the total debt to equity was 1.03. In terms of profitability, the gross margin trailing 12 months is 15.40%. The trailing 12-month EBITDA margin is 20.87% while for the period ending March 30, AdaptHealth Corp.’s operating margin was 5.10%. The firm’s gross profit as reported stood at $417.43 million against revenue of $2.97 billion.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -165.75% to $15.71 million, while revenue of -$2.59 million was 116.49% off the previous quarter. Analysts expected AHCO to announce $0.08 per share in earnings in its latest quarter, but it posted $0.11, representing a 37.50% surprise. EBITDA for the quarter stood at more than $121.3 million. AHCO stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 3.12 billion, with total debt at $2.34 billion. Shareholders hold equity totaling $134.17 million.
Let’s look briefly at AdaptHealth Corp. (AHCO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 47.79% to suggest the stock is trending Neutral, with historical volatility in this time period at 21.95%.
The stock’s 5-day moving average is $13.53, reflecting a -3.20% or -$0.44 change from its current price. AHCO is currently trading +5.64% above its 20-day SMA, +0.23% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +21.57% and SMA200 by-37.65%.
Stochastic %K and %D was 20.18% and 27.94% and the average true range (ATR) pointed at 0.51. The RSI (14) points at 54.38%, while the 14-day stochastic is at 12.88% with the period’s ATR at 0.51. The stock’s 9-day MACD Oscillator is pointing at -0.10 and -0.26 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for AdaptHealth Corp. (NASDAQ: AHCO), Stifel downgraded it to a Hold rating. They previously had a Buy rating on the stock. Analysts offering their rating for AHCO stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate AHCO as a “sell,”, while 3 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 6 have offered a “buy” rating.
What is AHCO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $11.00 and a high of $21.00, with their median price target at $15.50. Looking at these predictions, the average price target given by analysts is for AdaptHealth Corp. (AHCO) stock is $15.73.
